LobbyingMidsized Biotech Alliance of America lobbying by quarter
Midsized Biotech Alliance of America's latest lobbying report covers Q2 2026, at $230K. Its first report covers Q1 2026; the issues it reports most are Medicare/Medicaid and Pharmacy.
Midsized Biotech Alliance of America
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $460K
- Last 3 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2026 | $230K | 1 |
| Q2 2026 | $230K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$230K · 2 reports
- Pharmacy$230K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| LMH Strategic Solutions | $460K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ALANNA TEMME | Legislative Director, U.S. Representative Jon Porter | Q2 2026 |
| AMY CHEVALIER EFANTIS | Legislative Director, Rep. Artur Davis; Legislative Assistant, Rep. Tom Barrett | Q2 2026 |
| SOPHIE KHANAHMADI | Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions | Q1 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/05for Q2 | LMH Strategic Solutions | $230K |
| 04/20for Q1 | LMH Strategic Solutions | $230K |
| 04/17for Q1 | LMH Strategic Solutions | Under $5,000 |